| Educational Session | 09:00~10:10 | ||
| 1. Innovative treatment in medical oncology | Room A | ||
| 1) Lung cancer | |||
| Byoung Chul Cho (Yonsei University College of Medicine) | |||
| 2) Stomach cancer | |||
| Do-Youn Oh (Seoul National University College of Medicine ) | |||
| 3) Melanoma | |||
| Eun Joo Kang (Korea University College of Medicine) | |||
| 2. Role of radiation therapy in lymphoma: When and how? | Room B | ||
| 1) Radiotherapy in indolent non-Hodgkin's lymphoma, NK T-cell lymphoma, and Hodgkin's lymphoma | |||
| Chang-Ok Suh (Yonsei University College of Medicine) | |||
| 2) RT in aggressive and highly aggressive non-Hodgkin's lymphoma | |||
| Yong Chan Ahn (Sungkyunkwan University School of Medicine) | |||
| 3. Cancer surgery: What's your opinion for tailored approach? | Room C | ||
| 1) Gastric cancer surgery | |||
| Hoon Hur (Ajou University School of Medicine) | |||
| 2) Colorectal cancer | |||
| In Kyu Lee (The Catholic University of Korea College of Medicine) | |||
| 3) Breast cancer | |||
| Sang Uk Woo (Korea University College of Medicine) | |||
| Plenary Lecture 3 | 10:30~11:10, Room A ~ C | ||
| Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans | |||
| Tae-Ho Hwang, DDS, Ph.D. (Pusan National University) | |||
| Plenary Lecture 4 | 11:10~12:00, Room A ~ C | ||
| Adult Survivors of Sarcoma | |||
| Laurence H. Baker, DO (University of Michigan Medical School, USA) | |||
| Symposium 5 | 13:50~15:30, Room A | ||
| Recent issues in early phase clinical trial | |||
| 1) Early phase clinical trial: Overview | |||
| Joon Oh Park (Sungkyunkwan University School of Medicine) | |||
| 2) Recent issues in phase II Clinical trials | |||
| Sin-Ho Jung (Samsung Medical Center) | |||
| 3) Early phase clinical trial design in the era of targeted agents | |||
| Byung-Ho Nam (National Cancer Center) | |||
| 4) Biomarker exploration in early phase clinical trial | |||
| Seock-Ah Im (Seoul National University College of Medicine) | |||
| Symposium 6 | 13:50~15:30, Room C | ||
| Circulating tumor DNA | |||
| 1) Monitoring EGFR T790M with plasma DNA in lung cancer patients treated with EGFR tyrosine kinase inhibitor in prospective observational study | |||
| Naoko Sueoka-Aragane (Saga University, Japan) | |||
| 2) Extracellular vesicles and miRNA as emerging cancer biomarker for liquid biopsy | |||
| Yusuke Yoshioka (National Cancer Center Research Institute, Japan) | |||
| 3) Extracellular vesicles and circulating extracellular nucleic acids | |||
| Yong Song Gho (POSTECH) | |||
| Symposium 7 | 13:50~15:30, Room D | ||
| Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) | |||
| I: Clinical new paradigm in gynecologic cancer | |||
1) Recent advances in management of recurrent and metastatic cervical cancer: a focus on target therapies |
|||
| Jong-Min Lee (Kyung Hee University School of Medicine) | |||
2) Updates on recent landmark clinical trials in ovarian cancer |
|||
| Byoung-Gie Kim (Sungkyunkwan University School of Medicine) | |||
3) Molecular predictors of response and outcomes in gynecologic cancer |
|||
| Yong Man Kim (University of Ulsan College of Medicine) | |||
| II: Understanding translational research for gynecologic cancer | |||
1) Advances in stem cell research in gynecologic cancer |
|||
| Chi-Heum Cho (Keimyung University School of Medicine) | |||
2) Molecular classification of ovarian and endometrial cancers: clinical implication of 'The cancer genome atlas' |
|||
| Jae-Weon Kim (Seoul National University College of Medicine) | |||
3) Identifying novel therapeutic molecular targets in gynecologic cancer |
|||
| Jae-Hoon Kim (Yonsei University College of Medicine) | |||
| Symposium 8 | 15:50~17:30, Room A | ||
| Assessment for quality of cancer treatment | |||
1) Quality measurement of cancer care in HIRA |
|||
| Chang-Hak Sohn (Health Insurance Review & Assessment Service) | |||
2) Assessment for quality of lung cancer treatment |
|||
| Ki Hyeong Lee (Chungbuk National University College of Medicine) | |||
3) Evaluation of clinical practice in gastric cancer |
|||
| Keun Won Ryu (National Cancer Center) | |||
4) The outcomes of transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil for unresectable hepatocellular carcinoma |
|||
| Seung Kew Yoon (The Catholic University of Korea College of Medicine) | |||
| Symposium 9 | 15:50~17:30, Room B | ||
| Joint Symposium (Korean Cancer Association & Korean Association of Thyroid and Endocrine Surgeons) | |||
| Controversies in the treatment of thyroid cancer | |||
1) Controversies on microcarcinoma |
|||
| Surgical strategy for papillary thyroid microcarcinoma Young Don Lee (Gachon University School of Medicine) Controversies on microcarcinoma Jae Hoon Chung (Sungkyunkwan University School of Medicine) |
|||
2) Controversies on RAI treatment |
|||
| Controversies on RAI treatment of thyroid cancer Jeong Soo Kim (The Catholic University of Korea College of Medicine) Controversies of radioactive iodine treatment in thyroid carcinoma June-Key Chung (Seoul National University College of Medicine) |
|||
3) Controversies on refractory thyroid cancer |
|||
| Hang-Seok Chang (Yonsei University College of Medicine)
The role of external beam radiation and targeted therapy Young Joo Park (Seoul National University College of Medicine) |
|||
| Symposium 10 | 15:50~17:30, Room C | ||
| Patient driven xenograft | |||
1) Patient derived xenographs : The Jackson Laboratory experience |
|||
| Charles Lee (The Jackson Laboratory for Genomic Medicine, USA) | |||
2) Development and characterization of patient driven xenograft tumor model generated from primary cultured cells |
|||
| Se Jin Jang (University of Ulsan College of Medicine) | |||
3) Experimental and practical approaches to the establishment of patient-derived tumor xenograft model |
|||
| Jeong-Seok Nam (Gachon University School of Medicine) | |||
4) PDX model in breast cancer |
|||
| Hyeong-Gon Moon (Seoul National University College of Medicine) | |||
| International Session | |||
| Clinical 9 | 13:50~15:30, Room B | ||
| Oral Presentation | |||
| Radiation oncology | 13:50~14:40, Room E | ||
| Supportive care | 14:40~15:30, Room E | ||
| Gy cancer 1, 2 | 15:50~16:50, Room D | ||
| Other cancer | 17:00~17:30, Room D | ||
| Lung cancer | 15:50~16:50, Room E | ||
| Head & Neck cancer | 16:50~17:30, Room E | ||
| Luncheon Symposium 2 | 12:00~13:00, Room A ~ C | ||
The past, present and future for colorectal cancer |
|||
| Yong Sang Hong (University of Ulsan College of Medicine) | |||
| General Assembly | 13:00~13:30, Room A ~ C | ||
| Poster | 09:00~17:00, Room F | ||